UVB in the management of early stage mycosis fungoides

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 5, 2006, Pages 565-572

  Pavlotsky, Felix ^a   Barzilai, A ^a   Kasem, R ^a   Shpiro, D ^a   Trau, H ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BURN; CLINICAL PROTOCOL; CONTROLLED STUDY; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; PRURITUS; PUVA; RELAPSE; RETROSPECTIVE STUDY; SCHOOL CHILD; STATISTICAL ANALYSIS; SUN EXPOSURE; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CHILD; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; RECURRENCE; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 33646046471     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01557.x     Document Type: Article

References (40)

1. Bunn PA, Lamberg SI. Report of the committee on staging and classification of cutaneous T-cell lymphoma. Cancer Treat Rep 1979; 68: 725-728.
2. Kashani-Sabet M, McMillan A, Zackheim HS. A modified staging classification for cutaneous T-cell lymphoma. J Am Acad Dermatol 2001; 45: 700-706.
3. Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome. Clinical prognostic factors and risk for disease progression. Arch Dermatol 2003; 139: 857-866.
4. Kim YH, Chow S, Varghese A, Hoppe RT. Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides. Arch Dermatol 1999; 135: 26-32.
5. Zackheim HS. Treatment of patch-stage mycosis fungoides with topical corticosteroids. Dermatol Ther 2003; 16: 283-287.
6. Zackheim HS. Topical carmustine (BCNU) in the treatment of mycosis fungoides. Dermatol Ther 2003; 16: 299-302.
7. Kim YH, Martinez G, Varghese A, Hoppe RT. Topical nitrogen mustard in the management of mycosis fungoides. Update of the Stanford experience. Arch Dermatol 2003; 139: 165-173.
8. Hoppe RT. Mycosis fungoides: Radiation therapy. Dermatol Ther 2003; 16: 347-354.
9. Gilchrest BA, Parrish JA, Tanenbaum L et al. Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer 1976; 38: 683-689.
10. Roenigk HH Jr. Photochemotherapy for mycosis fungoides. Arch Dermatol 1977; 113: 1047-1051.
11. Vella Briffa D, Warin AP, Harrington CI et al. Photochemotherapy in mycosis fungoides. Lancet 1980; 2: 49-53.
12. Honigsmann H, Brenner W, Rauschmeier W et al. Photochemotherapy for cutaneous T cell lymphoma. J Am Acad Dermatol 1984; 10: 238-245.
13. Powell FC, Spiegel GT, Muller SA. Treatment of parapsoriasis and mycosis fungoides: The role of psoralen and long-wave ultraviolet light A (PUVA). Mayo Clin Proc 1984; 59: 538-546.
14. Hermann JJ, Roenigk HH, Hurria A et al. Treatment of mycosis fungoides with photochemotherapy (PUVA): Long-term follow up. J Am Acad Dermatol 1995; 33: 234-242.
15. Diederen PVM, van Weelden H, Sanders CJG, Toonstra J, van Vloten WA. Narrowband UVB and psoralen-UVA in the treatment of early stage mycosis fungoides: A retrospective study. J Am Acad Dermatol 2003; 48: 215-219.
16. Honigsmann H, Tanem A, Wolff K. Treatment of mycosis fungoides with PUVA. Photodermatology 1987; 4: 55-58.
17. Roupe G, Sandstrom MH, Kjellstrom C. PUVA in early mycosis fungoides may give long term remission and delay extracutaneous spread. Acta Derm Venereol 1996; 76: 475-478.
18. Zane C, Leali C, Airo P, De Panfilis G, Pinton PC. 'High-dose' UVA1 therapy of widespread plaque-type, nodular, and erythrodermic mycosis fungoides. J Am Acad Dermatol 2001; 44: 629-633.
19. Tippel H, Engst R. Mycosis Fungoides. Results of helioclimate therapy in high mountains (Davos, 1560). Hautarzt 1986; 37: 450-453. (in German.)
20. Ramsay DL, Lish KM, Yalowitz CB, Soter NA. Ultraviolet-B phototherapy for early-stage cutaneous T-cell lymphoma. J Am Arch Dermatol 1992; 128: 931-933.
21. Resnik KS, Vonderheid EC. Home UV phototherapy of early mycosis fungoides: Long-term follow-up observations in thirty-one patients. J Am Arch Dermatol 1993; 29: 73-77.
22. Milstein HJ, Vonderheid EC, Van Scott EJ, Johnson WC. Home ultraviolet phototherapy of early mycosis fungoides: Preliminary observations. J Am Acad Dermatol 1982; 6: 355-362.
23. Hofer A, Cerroni L, Keri H, Wolf P. Narrow band (311-nm) UVB therapy for small plaque parapsoriasis and early stage mycosis fungoides. Arch Dermatol 1999; 135: 1377-1380.
24. Clark C, Dawe RS, Evans AT, Lowe G, Ferguson J. Narrow band TL-01 phototherapy for patch stage mycosis fungoides. Arch Dermatol 2000; 136: 748-752.
25. Gathers RC, Scherschun L, Malick F, Fivenson DP, Lim HW. Narrowband UBV phototherapy for early-stage mycosis fungoides. J Am Acad Dermatol 2002; 47: 191-197.
26. Baron ED, Stevens SR. Phototherapy for cutaneous T-cell lymphoma. Dermatol Ther 2003; 16: 303-310.
27. Stevens SR, Ke MS, Birol A et al. Interdisciplinary Cutaneous Lymphoma Program. A simple clinical scoring system to improve the sensitivity and standardization of the diagnosis of mycosis fungoides type cutaneous T-cell lymphoma: Logistic regression of clinical and laboratory data. Br J Dermatol 2003; 149: 513-522.
28. Santucci M, Biggeri A, Feller AC, Massi D, Burg G. Efficacy of histologic criteria for diagnosing early mycosis fungoides: An EORTC cutaneous lymphoma Study Group investigation. European Organization for Research and Treatment of Cancer. Am J Surg Pathol 2000; 24: 40-50.
29. Muche JM, Sterry W, Gellrich S, Rzany B, Audring H, Lukowsky A. Peripheral blood T-cell clonality in mycosis fungoides and nonlymphoma controls. Diagn Mol Pathol 2003; 12: 142-150.
30. Howard MS, Smoller BR. Mycosis fungoides: Classic disease and variant presentations. Semin Cutan Med Surg 2000; 19: 91-99.
31. Hodak E, David M. Follicular mycosis fungoides. J Cutan Pathol 2002; 29: 625.
32. Kaye FJ, Bunn PA, Steinberg SM et al. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 1989; 321: 1784-1790.
33. Vonderheid EC, Tan ET, Kantor AF, Shrager L, Micaily B, Van Scott EJ. Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T-cell lymphoma. J Am Acad Dermatol 1989; 20: 416-428.
34. Piccinno R, Caccialanza M, Mainardi L. Confront tra I risultati ottenuti co radiazione ultravioletta e con fotochemioterapia negli staid iniziali della micosi fungoide. G Ital Dermatol Venereol 1990; 125: 91-95.
35. Mackie RM, Foulds IS, McMillan EM, Nelson H. Histological changes observed in the skin of patients with mycosis fungoides receiving photochemotherapy. Clin Exp Dermatol 1980; 5: 405-413.
36. Cerroni L, Arzberger E, Ardigo M, Putz B, Kerl H. Monoclonality of intraepidermal T lymphocytes in early mycosis fungoides detected by molecular analysis after laser-beam-based microdissection. J Invest Dermatol 2000; 114: 1154-1157.
37. De Gruijl FR. Long-term side effects and carcinogenesis risk in UVB therapy. In: Honigsmann H, Jori G, Young AR, eds. The Fundamental Bases of Phototherapy. OEMF Spa, Milan, 1996: 153-170.
38. Young A. Carcinogenicity of UVB phototherapy assessed. Lancet 1995; 345: 1431-1432.
39. Stern RS, Laird N. The carcinogenic risk of treatments for severe psoriasis: Photochemotherapy follow-up study. Cancer 1994; 73: 2759-2764.
40. Stern RS, Nichols KT, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA): The PUVA follow-up study. N Engl J Med 1997; 336: 1041-1045.